Стоит ли избегать methylthiophenyl morpholino isobutanone при беременности? | VeriMom
This substance (2‑methyl‑1‑(4‑methylthiophenyl)‑2‑morpholinopropan‑1‑one; CAS 71868‑10‑5) has an EU harmonised CLP classification as Toxic for Reproduction Category 1B, H360FD (“May damage fertility. May damage the unborn child”), which places it in the highest reproductive hazard category and justifies h=3. ECHA’s supporting background/briefing documents and Annex VI entry report reproductive toxicity data from regulatory assessments (animal datasets) though a specific molecular mechanism is not fully characterised; therefore m=2 (demonstrated effect in studies). Topical cosmetic exposure data are limited and it has historically been used in non‑leave‑on products / industrial applications; in absence of quantitative dermal absorption data I score exposure as low but measurable (e=1). Sources: ECHA harmonised CLP / Annex VI recommendation and background documents, ECHA brief profile.
ECHA regulatory hazard statements
- •H360FD
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Безопасен ли methylthiophenyl morpholino isobutanone при беременности?
- This substance (2‑methyl‑1‑(4‑methylthiophenyl)‑2‑morpholinopropan‑1‑one; CAS 71868‑10‑5) has an EU harmonised CLP classification as Toxic for Reproduction Category 1B, H360FD (“May damage fertility. May damage the unborn child”), which places it in the highest reproductive hazard category and justifies h=3. ECHA’s supporting background/briefing documents and Annex VI entry report reproductive toxicity data from regulatory assessments (animal datasets) though a specific molecular mechanism is not fully characterised; therefore m=2 (demonstrated effect in studies). Topical cosmetic exposure data are limited and it has historically been used in non‑leave‑on products / industrial applications; in absence of quantitative dermal absorption data I score exposure as low but measurable (e=1). Sources: ECHA harmonised CLP / Annex VI recommendation and background documents, ECHA brief profile.
- Безопасен ли methylthiophenyl morpholino isobutanone при грудном вскармливании?
- Harmonised H360FD (may damage fertility and the unborn child) indicates high reproductive hazard (h=3) and the regulatory dossier shows animal reproductive toxicity evidence (m=2). There are no public quantitative data on human milk transfer; exposure from typical topical cosmetic use is likely low but measurable (e=1) — breastfeeding concern derives from systemic hazard plus potential for maternal systemic exposure. Sources: ECHA harmonised classification and background documents.
- Безопасен ли methylthiophenyl morpholino isobutanone для кожи малыша?
- Hazard (h=3) remains because of the substance’s harmonised H360FD reproduction/teratogenic classification. Mechanistic evidence remains regulatory/animal‑based rather than a well‑characterised molecular pathway (m=2). For infant skin (0–3 yr) exposure I increase exposure by +1 relative to adults (adult e=1 → baby e=2) because infant skin has higher surface‑area‑to‑weight and an immature barrier and there are no reliable dermal absorption data showing non‑absorbability. Together this yields higher concern for use on or near infants. Sources: ECHA harmonised CLP / background documents; PubChem substance record.
- Как VeriMom оценивает methylthiophenyl morpholino isobutanone?
- VeriMom оценивает methylthiophenyl morpholino isobutanone в 20/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы methylthiophenyl morpholino isobutanone при беременности?
- См. наш список безопасных альтернатив methylthiophenyl morpholino isobutanone с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.